ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 160 filers reported holding ANIKA THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $554 | -51.4% | 29,725 | -32.2% | 0.00% | -66.7% |
| Q2 2023 | $1,139 | +41.7% | 43,842 | +56.6% | 0.00% | +50.0% |
| Q1 2023 | $804 | -23.4% | 27,989 | -21.1% | 0.00% | -33.3% |
| Q4 2022 | $1,049 | -99.8% | 35,459 | +24.0% | 0.00% | +50.0% |
| Q3 2022 | $681,000 | +25.6% | 28,602 | +17.8% | 0.00% | +100.0% |
| Q2 2022 | $542,000 | +83.7% | 24,288 | +106.7% | 0.00% | 0.0% |
| Q1 2022 | $295,000 | -29.9% | 11,753 | +0.0% | 0.00% | 0.0% |
| Q4 2021 | $421,000 | -15.1% | 11,749 | +0.8% | 0.00% | 0.0% |
| Q3 2021 | $496,000 | -2.6% | 11,658 | -0.9% | 0.00% | 0.0% |
| Q2 2021 | $509,000 | +6.0% | 11,765 | -0.1% | 0.00% | 0.0% |
| Q1 2021 | $480,000 | -9.9% | 11,772 | -0.1% | 0.00% | 0.0% |
| Q4 2020 | $533,000 | +27.8% | 11,780 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $417,000 | -6.9% | 11,780 | -0.9% | 0.00% | 0.0% |
| Q2 2020 | $448,000 | +29.5% | 11,887 | -0.6% | 0.00% | 0.0% |
| Q1 2020 | $346,000 | -41.3% | 11,959 | +5.3% | 0.00% | -50.0% |
| Q4 2019 | $589,000 | -2.0% | 11,362 | +3.8% | 0.00% | 0.0% |
| Q3 2019 | $601,000 | +32.7% | 10,951 | -1.8% | 0.00% | +100.0% |
| Q2 2019 | $453,000 | +38.1% | 11,149 | +2.8% | 0.00% | 0.0% |
| Q1 2019 | $328,000 | -7.3% | 10,849 | +3.1% | 0.00% | 0.0% |
| Q4 2018 | $354,000 | -18.4% | 10,520 | +2.2% | 0.00% | 0.0% |
| Q3 2018 | $434,000 | +34.0% | 10,289 | +1.7% | 0.00% | 0.0% |
| Q2 2018 | $324,000 | -31.1% | 10,115 | +6.9% | 0.00% | -50.0% |
| Q1 2018 | $470,000 | -4.5% | 9,458 | +3.7% | 0.00% | 0.0% |
| Q4 2017 | $492,000 | -5.2% | 9,120 | +2.0% | 0.00% | 0.0% |
| Q3 2017 | $519,000 | +19.6% | 8,940 | +1.6% | 0.00% | 0.0% |
| Q2 2017 | $434,000 | +21.2% | 8,800 | +6.8% | 0.00% | 0.0% |
| Q1 2017 | $358,000 | -7.7% | 8,240 | +4.0% | 0.00% | 0.0% |
| Q4 2016 | $388,000 | +7.8% | 7,920 | +5.2% | 0.00% | 0.0% |
| Q3 2016 | $360,000 | -4.0% | 7,530 | +7.7% | 0.00% | 0.0% |
| Q2 2016 | $375,000 | +28.4% | 6,990 | +7.2% | 0.00% | +100.0% |
| Q1 2016 | $292,000 | +21.2% | 6,520 | +3.2% | 0.00% | 0.0% |
| Q4 2015 | $241,000 | +7.6% | 6,320 | +16.0% | 0.00% | 0.0% |
| Q1 2015 | $224,000 | +4.7% | 5,450 | +3.8% | 0.00% | 0.0% |
| Q4 2014 | $214,000 | – | 5,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 490,331 | $21,928,000 | 10.27% |
| CAPITAL MANAGEMENT CORP /VA | 211,660 | $9,465,000 | 3.66% |
| AMI ASSET MANAGEMENT CORP | 336,791 | $15,061,000 | 1.03% |
| Baltimore-Washington Financial Advisors, Inc. | 68,785 | $3,076,000 | 0.93% |
| Portolan Capital Management | 130,939 | $5,856,000 | 0.78% |
| Kalos Management, Inc. | 19,254 | $861,000 | 0.72% |
| DIKER MANAGEMENT LLC | 32,965 | $1,474,000 | 0.56% |
| THOMPSON SIEGEL & WALMSLEY LLC | 1,526,244 | $68,253,000 | 0.56% |
| NEW AMSTERDAM PARTNERS LLC/NY | 108,260 | $4,841,000 | 0.51% |
| Boston Trust Walden Corp | 493,780 | $22,082,000 | 0.38% |